Adage Capital Partners’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
301,361
-215,194
| -42% | -$9.29M | 0.02% | 559 |
|
|
2025
Q1 | $17.9M | Buy |
516,555
+246,555
| +91% | +$8.52M | 0.03% | 447 |
|
|
2024
Q4 | $7.41M | Buy |
+270,000
| New | +$7.41M | 0.01% | 665 |
|
|
2024
Q3 | – | Sell |
-548,000
| Closed | -$13.9M | – | 878 |
|
|
2024
Q2 | $13.9M | Buy |
548,000
+272,000
| +99% | +$6.89M | 0.03% | 529 |
|
|
2024
Q1 | $8.53M | Buy |
+276,000
| New | +$8.53M | 0.02% | 625 |
|
|
2023
Q1 | – | Sell |
-378,215
| Closed | -$2.88M | – | 925 |
|
|
2022
Q4 | $2.88M | Buy |
378,215
+278,215
| +278% | +$2.12M | 0.01% | 795 |
|
|
2022
Q3 | $994K | Buy |
+100,000
| New | +$994K | ﹤0.01% | 891 |
|